Reveal HealthTech secures $7.2M funding for AI healthcare

96

News Summary

Reveal HealthTech, an ambitious AI healthcare startup bridging the U.S. and India, has secures $7.2 million in Series A funding, led by Leo Capital and supported by Sanos Capital. Founded in 2023 by Sanchit Mullick, Dr. Salim Afshar, and Andrew Bravo, the company is determined to shake up healthcare, rethinking patient engagement, clinical workflows, and operational efficiency through AI. This fresh capital isn’t just numbers on a sheet; it’s a launchpad for Reveal to scale its AI platforms, strengthen its sales network, and forge meaningful connections with healthcare and life sciences leaders across the globe. The startup has also joined the Cipher Collective, an ECG-powered AI partner network, signaling its intent to lead collaborative innovation in healthcare.

With talent drawn from MIT, Harvard, UC Berkeley, NASA, and SpaceX, Reveal HealthTech isn’t just chasing AI hype it’s aiming to make AI a measurable, accountable ally in healthcare, enhancing patient outcomes while streamlining operations. This Series A milestone is more than a financial win; it’s a springboard for global expansion.

1. Introduction

1.1 What is Reveal HealthTech?

Founded in 2023, Reveal HealthTech is staking its claim as a bold, AI-first player in healthcare technology. Its main playground? Hospitals, medical device makers, and life sciences organizations are desperate for smarter, faster, and more reliable workflows. By fusing hands-on clinical know-how with cutting-edge AI, Reveal isn’t just promising efficiency, it’s cutting through the bureaucratic clutter, anticipating patient adherence patterns, and accelerating research like few others dare to attempt.

Headquartered in New York with a development powerhouse in Bengaluru, Reveal bridges global expertise with engineering that scales. Its sweet spot lies in AI-driven workflow automation, predictive patient monitoring, and multimodal clinical data integration, a trifecta that gives it a distinct edge in a healthcare AI market that’s becoming noisier by the day.

1.2 Series A Funding Milestone

In September 2025, Reveal HealthTech raised $7.2 million in its Series A round. Leo Capital led the investment, with Sanos Capital joining in. The funds aim to scale AI platforms, reinforce commercial operations, and extend market presence.

Investors are particularly impressed with Reveal’s ability to deliver measurable business impact through AI. Dr. Pankaj Jethwani of W Health Ventures commented, “Healthcare isn’t solved with cookie-cutter solutions. Reveal’s approach ensures AI genuinely moves the needle for organizations.”

2. Founders and Leadership

2.1 Sanchit Mullick – Visionary CEO

Sanchit Mullick, the CEO, has spent over twenty years navigating digital transformation and technology services. His previous stints at Infosys and GlobalLogic shaped his pragmatic approach: AI in healthcare isn’t just theory it’s actionable tools for real-world problems.

He notes, “Most think of AI as clinical decision support. But there’s a broader canvas—optimizing workflows, predicting device adherence, tracking screenings, and improving home-based care scheduling.”

2.2 Dr. Salim Afshar – Clinical Innovation Lead

Dr. Afshar, with his Harvard surgical training and engineering background, ensures that Reveal’s AI stays clinically relevant, safe, and effective. His work bridges technology and bedside care, which is rare in an AI-heavy sector.

2.3 Andrew Bravo – Business Strategy Lead

Andrew Bravo oversees business development and strategic growth. Beyond building AI solutions, he ensures they reach the right audience and generate tangible impact for healthcare organizations.

3. Core Offerings and Solutions

3.1 BioCanvas® – Accelerating Clinical Trials

BioCanvas® is Reveal’s flagship AI platform, integrating lab reports, genetic data, imaging, and patient records to streamline clinical trial recruitment. In one deployment for a $40 billion U.S. medical device company, it boosted patient adherence by 10–15%, offering a reusable blueprint for other clients.

3.2 Prism AI® – Workflow Automation

Prism AI® automates routine clinical workflows. Scheduling, reporting, patient monitoring all can now run with minimal human intervention, freeing healthcare teams to focus on patient care and operational efficiency.

3.3 Patient Adherence Prediction

Reveal’s predictive AI identifies patients at risk of non-compliance and tailors interventions accordingly. The result: better outcomes for patients and improved utilization and profitability for providers.

4. Business Model and Revenue Streams

4.1 AI Solutions Provider

Reveal operates as a hybrid AI solutions and consulting firm. Revenue comes from:

• Subscription access to BioCanvas® and Prism AI®
• Custom AI model development
• Consulting for AI integration and workflow redesign

4.2 Strategic Partnerships

Partnerships with W Health Ventures and 2070 Health have propelled Reveal into the AI healthcare space, providing mentorship, funding, and hospital network access.

5. Industry Landscape and Growth Trends

5.1 AI Transforming Healthcare

AI in healthcare is no longer a luxury it’s becoming a necessity. Reveal HealthTech enables providers to analyze massive datasets, detect patterns, and improve outcomes.

5.2 Market Growth and Opportunity

The global AI healthcare market isn’t just inching forward it’s charging ahead, projected to soar to nearly $45 billion by 2030 with a staggering 40% CAGR. What’s fueling this momentum? A cocktail of forces: the rapid adoption of telemedicine, the mainstreaming of electronic health records, and a growing appetite for digital health solutions that cut costs while boosting efficiency.

In this whirlwind of growth, Reveal HealthTech finds itself in a sweet spot. Its sharp focus on predictive patient adherence and workflow automation aligns perfectly with where the industry is heading. While plenty of players are dabbling in AI, Reveal’s approach feels more grounded aimed not at flashy gimmicks, but at solving stubborn, day-to-day problems that bleed time and money from healthcare providers.

6. Competitor Landscape

6.1 Direct Competitors

• Centivo – AI-driven healthcare plans
• Access Healthcare – Revenue cycle and patient management

Reveal differentiates itself with deeper clinical integration and multimodal AI applications.

6.2 Indirect Competitors

Telemedicine platforms, EHR systems, and analytics firms also push healthcare digitization, even if not purely AI-focused.

7. Strategic Initiatives and Future Plans

7.1 Expansion of AI Capabilities

Reveal is enhancing machine learning models to cover oncology, chronic disease, and remote care.

7.2 Strengthening Sales & Marketing

Scaling adoption requires a robust sales force, targeted digital campaigns, and presence at global events.

7.3 Global Expansion

Reveal is tailoring AI platforms for international compliance and operational norms.

8. Learning for Startups and Entrepreneurs

8.1 Specialized Expertise Matters

Deep domain knowledge, coupled with technology, is essential in complex industries like healthcare.

8.2 Strategic Partnerships Accelerate Growth

Funding, mentorship, and networks can propel startups from concept to scalable operations.

8.3 Focus on Scalability

Solutions must handle growing data volumes and client expansion without friction.

Foundlanes Perspective

Foundlanes tracks Indian and global startup stories. Reveal HealthTech’s Series A success underscores AI’s transformative role in healthcare. Highlighting milestones like this helps entrepreneurs and investors understand the sector’s rapidly evolving landscape.